Lupin Signs a Licensing Agreement to Market Vonoprazan in India
Pharmaceutical major, Lupin Ltd on 18 September announced that they have signed a non-exclusive patent licensing arrangement to bring the novel gastrointestinal medication Vonoprazan tablets